Clinical Trials Finder

Dialysis Clinical Trials: Recruiting Studies

Recruiting dialysis clinical trials, listed from live ClinicalTrials.gov records with each trial's official title, phase, conditions, locations and a direct link to its full record.

These listings cover recruiting studies involving dialysis — including haemodialysis and peritoneal dialysis care, symptoms during treatment and dialysis adequacy — exactly as the ClinicalTrials.gov records describe them. A listing here is not a recommendation: your dialysis unit and nephrologist are the right people to judge whether any study fits your treatment plan.

Trial data from ClinicalTrials.gov, fetched November 17, 2026 — always confirm details on the trial's own page.

Recruiting trials, most recently updated first

Showing the 20 most recently updated recruiting trials from a search that matched 184 records in total on the fetch date. The full, live list is on ClinicalTrials.gov.

Intradialytic Benson's Relaxation Technique on Dialysis Adequacy and Sleep Quality in Patients With Chronic Kidney Disease

NCT07935980 · Status: Recruiting · Phase: Not applicable · Conditions: Patients With Chronic Kidney Disease, Intradialytic Benson's Relaxation Technique, Dialysis Adequacy, Sleep Quality · Last updated: 2026-11-13

The purpose of this study is to determine the impact of benson's relaxation technique on dialysis adequacy and sleep quality among CKD patients. The intervention will include intradialytic benson's relaxation sessions, and outcomes such dialysis adequacy and sleep quality will be evaluated after 12 weeks of benson's…

1 study locations, none listed in the United States (including Cairo, Egypt).

View this trial on ClinicalTrials.gov (NCT07935980)

A Multi-center, Single Arm, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Iptacopan in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Who Have Completed a Preceding Iptacopan Phase 3 Study in aHUS

NCT05795140 · Status: Recruiting · Phase: Phase 3 · Conditions: Atypical Hemolytic Uremic Syndrome · Last updated: 2026-11-12

This is a multicenter, single arm, open-label, extension study to evaluate the long-term safety, tolerability, and efficacy of iptacopan in participants with aHUS.

10 study locations, none listed in the United States (including São Paulo, São Paulo; Rio de Janeiro, Brazil; Beijing, China).

View this trial on ClinicalTrials.gov (NCT05795140)

Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial

NCT07910773 · Status: Recruiting · Phase: Not applicable · Conditions: End Stage Kidney Disease (ESKD), Hypertension (HTN), Peritoneal Dialysis (PD) · Last updated: 2026-11-06

The GOAL-BP pilot study will help determine whether a study comparing two blood pressure goals can be carried out in adults with end-stage kidney disease and high blood pressure who receive peritoneal dialysis. The main questions it aims to answer are whether eligible patients can be recruited for the study.…

3 study locations, 3 in the United States (including San Francisco, California).

View this trial on ClinicalTrials.gov (NCT07910773)

A Multicenter, Randomized, Double-blind, Double-dummy, Phase III Study to Evaluate the Efficacy and Safety of MT1013 Versus Cinacalcet as Active Control in Secondary Hyperparathyroidism Patients on Maintenance Dialysis

NCT07122401 · Status: Recruiting · Phase: Phase 3 · Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease · Last updated: 2026-11-05

MT1013 is a first-in-class dual-target agonist. This study is a multicenter, randomized, double-blind, double-dummy phase III clinical study being conducetd to evaluate the efficacy and safety of MT1013 compared with active control cinacalcet in secondary hyperparathyroidism patients on maintenance dialysis. Subjects…

1 study locations, none listed in the United States (including Shanghai, Shanghai Municipality).

View this trial on ClinicalTrials.gov (NCT07122401)

Il Registro Italiano di Dialisi Pediatrica (RIDP) - Italian Registry of Pediatric Dialysis

NCT07918066 · Status: Recruiting · Phase: Not stated · Conditions: Dialysis, Kidney Transplantation · Last updated: 2026-11-05

The primary aim of the Registry, in addition to promoting collaboration and the sharing of protocols among participating centres, is to collect epidemiological, clinical, and biochemical data on patients, as well as technical data on dialysis treatments performed at Italian dialysis centres.

12 study locations, none listed in the United States (including Ancona, Italy; Bari, Italy; Bologna, Italy).

View this trial on ClinicalTrials.gov (NCT07918066)

A Phase 1, Non-randomized, Open-label, Multi-center Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intravenous Fosmanogepix in Adult Subjects With End-stage Renal Disease Requiring Intermittent Hemodialysis

NCT07916181 · Status: Recruiting · Phase: Phase 1 · Conditions: End Stage Renal Disease on Dialysis, Adult · Last updated: 2026-11-04

This study will evaluate how fosmanogepix is processed by the body (pharmacokinetics, PK) in participants with kidney failure (end-stage renal disease (ESRD) requiring intermittent hemodialysis (IHD) compared with participants with normal kidney function (control group). Fosmanogepix is given by intravenous infusion…

2 study locations, 2 in the United States (including Orlando, Florida; Tampa, Florida).

View this trial on ClinicalTrials.gov (NCT07916181)

Dry Weight Reduction Intervention Via Extra Ultrafiltration

NCT07637110 · Status: Recruiting · Phase: Not applicable · Conditions: Fluid Accumulation, Blood Pressure Management, End Stage Renal Disease (ESRD) · Last updated: 2026-10-30

Most patients who receive hemodialysis treatments have excess fluid in their body that has slowly built up over the course of kidney disease. This extra fluid is the main cause of high blood pressure in dialysis and leads to stress on the heart and lungs.that causes debilitating symptoms and frequent hospitalizations.…

1 study locations, 1 in the United States (including Seattle, Washington).

View this trial on ClinicalTrials.gov (NCT07637110)

The Safety and Efficacy of Empagliflozin in Patients With End-stage Renal Disease and Heart Failure With Reduced Ejection Fraction - a Randomized Controlled Trial

NCT06249932 · Status: Recruiting · Phase: Phase 4 · Conditions: Heart Failure With Reduced Ejection Fraction, End Stage Renal Disease on Dialysis · Last updated: 2026-10-28

In patients with ESRD, up to 20% of patients suffer from HFrEF, leading to significant CV morbidity and mortality. Several drug classes that provide survival benefits for patients with HFrEF, including SGLT2i, lack data regarding their efficacy and safety in patients under chronic hemodialysis. As the primary target…

2 study locations, none listed in the United States (including Hsinchu, Taiwan; Taipei, Taiwan).

View this trial on ClinicalTrials.gov (NCT06249932)

LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM): A Pilot Randomized Trial

NCT06446739 · Status: Recruiting · Phase: Not applicable · Conditions: Acute Kidney Injury, Dialysis; Complications · Last updated: 2026-10-28

An estimated 10-15% of critically ill patients with acute kidney failure in the intensive care unit receive acute dialysis therapy. The majority of these patients initially receive a continuous form of dialysis therapy call continuous renal replacement therapy (CRRT). Prior studies have suggested that higher CRRT…

10 study locations, 1 in the United States (including Rochester, Minnesota).

View this trial on ClinicalTrials.gov (NCT06446739)

Study of 3D Ultrasound for Support of Hemodialysis Cannulation

NCT07891741 · Status: Recruiting · Phase: Not applicable · Conditions: Dialysis · Last updated: 2026-10-27

This study is a prospective, single arm, multi-center two-stage feasibility study designed to evaluate the safety and effectiveness of the use of the EchoMap device to assist in traditional methods of AV fistula cannulation.

3 study locations, 3 in the United States (including Hartford, Connecticut; Middlebury, Connecticut; Greenville, South Carolina).

View this trial on ClinicalTrials.gov (NCT07891741)

The KidneyCARE (Community Access to Research Equity) Study: A National Registry for People With All Stages of Kidney Disease (Formerly National Kidney Foundation Patient Network)

NCT05497518 · Status: Recruiting · Phase: Not stated · Conditions: Chronic Kidney Disease, Dialysis, Kidney Transplant · Last updated: 2026-10-26

For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney…

1 study locations, 1 in the United States (including Danville, Pennsylvania).

View this trial on ClinicalTrials.gov (NCT05497518)

Laser Acupuncture Improves Fatigue and Quality of Life in Hemodialysis Patients: a Randomized Double-blind Clinical Trial Pilot Study

NCT07538310 · Status: Recruiting · Phase: Not applicable · Conditions: ESRD (End Stage Renal Disease), Dialysis, Fatigue · Last updated: 2026-10-26

The goal of this clinical trial is to learn if laser acupuncture (low-level laser therapy) works to treat fatigue and improve quality of life in adults with end-stage renal disease (ESRD) undergoing hemodialysis. It will also learn about how laser acupuncture affects blood circulation and autonomic nervous system…

1 study locations, none listed in the United States (including Taipei, Taiwan).

View this trial on ClinicalTrials.gov (NCT07538310)

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients: a Pilot Randomized Controlled Trial

NCT06483074 · Status: Recruiting · Phase: Phase 2 · Conditions: End Stage Renal Disease on Dialysis, Peritoneal Dialysis Complication, Sodium-glucose Cotransporter-2 Inhibitor, Residual Kidney Function · Last updated: 2026-10-22

Empagliflozin, a new class of diabetes medication, has demonstrated a reduction in renal function decline among patients with chronic kidney disease, regardless of their diabetes status. However, all previous studies excluded dialysis patients. Patients starting dialysis may still produce a certain amount of urine.…

1 study locations, none listed in the United States (including Hong Kong, Hong Kong).

View this trial on ClinicalTrials.gov (NCT06483074)

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients With Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy

NCT05758077 · Status: Recruiting · Phase: Not applicable · Conditions: Acute Kidney Injury · Last updated: 2026-10-22

This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to CKRT alone (standard…

36 study locations, 36 in the United States (including Birmingham, Alabama; Phoenix, Arizona; Los Angeles, California).

View this trial on ClinicalTrials.gov (NCT05758077)

Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)

NCT07059962 · Status: Recruiting · Phase: Not stated · Conditions: Kidney Disease, Peritoneal Dialysis (PD), End Stage Kidney Disease (ESRD) · Last updated: 2026-10-22

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

7 study locations, 4 in the United States (including Victorville, California; Augusta, Georgia; Chicago, Illinois).

View this trial on ClinicalTrials.gov (NCT07059962)

Continuous Glucose Monitoring as a Strategy to Optimize Metabolic Control in Patients With Diabetes on Peritoneal Dialysis Therapy Entitled to the IMSS

NCT06069518 · Status: Recruiting · Phase: Not stated · Conditions: Kidney Disease, Chronic, Peritoneal Dialysis, Diabetes Mellitus Type 2 · Last updated: 2026-10-21

Background: Patients with chronic kidney disease (CKD) caused by diabetes mellitus (DM) experience metabolic alterations characterized by elevated blood glucose levels and associated cardiovascular complications, which increase morbidity and mortality. Therefore, adequate metabolic control is necessary to reduce the…

2 study locations, none listed in the United States (including Mexico City, Mexico City).

View this trial on ClinicalTrials.gov (NCT06069518)

Multi-Centre Pragmatic Randomized Controlled Trial of Bowel Preparation Before Peritoneal Dialysis Catheter Insertion

NCT07351357 · Status: Recruiting · Phase: Phase 4 · Conditions: Renal Failure Chronic Requiring Dialysis, Peritoneal Dialysis · Last updated: 2026-10-21

Doctors need to insert catheter for patients who are going to have peritoneal dialysis. These peritoneal catheters can be obstructed or blocked afterward. The chance of not having smooth flow can be up to 12 and 31%. So far, constipation is one of the proposed reasons. Therefore, the study is aimed to investigate…

6 study locations, none listed in the United States (including Kwai Chung, Kowloon; Sham Shui Po, Kowloon; Shatin, NT).

View this trial on ClinicalTrials.gov (NCT07351357)

Predicting the Post-dialysis Rebound of β2-microglobulin

NCT07713680 · Status: Recruiting · Phase: Not stated · Conditions: Renal Disease, End Stage · Last updated: 2026-10-16

β2-Microglobulin is small 11.8 kDa protein presents on the surface of all nucleated cell in the human body, it forms part of the non-variable chain of Major Histocompatibility Complex class I. β2-Microglobulin production is constant and it is continuously released into the bloodstream. Its production increases during…

1 study locations, none listed in the United States (including Stevenage, United Kingdom).

View this trial on ClinicalTrials.gov (NCT07713680)

An International, Multi-centre, Randomised Controlled Trial Co-designed With Consumers With Lived Experience of Peritoneal Dialysis (PD) to Determine the Optimal Approach to Starting Patients With Kidney Failure on PD

NCT06642597 · Status: Recruiting · Phase: Not applicable · Conditions: Peritoneal Dialysis (PD), Kidney Failure · Last updated: 2026-10-15

Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially…

14 study locations, none listed in the United States (including Blacktown, New South Wales; Newcastle, New South Wales; Wollongong, New South Wales).

View this trial on ClinicalTrials.gov (NCT06642597)

Journey to Transplant: Virtual Coaching for Potential Kidney Transplant Patients and Their Social Support Networks

NCT06147076 · Status: Recruiting · Phase: Not applicable · Conditions: Kidney Transplant · Last updated: 2026-10-14

Virtual Coaching for Potential Kidney Transplant Patients

1 study locations, 1 in the United States (including Minneapolis, Minnesota).

View this trial on ClinicalTrials.gov (NCT06147076)

More from the Clinical Trials Finder

This page is general information only. It is not medical advice, it does not say whether any trial is right for you, and it makes no promise about eligibility or enrollment. Clinical trials have eligibility criteria set by the trial team, and taking part is always voluntary. Talk to your own care team before contacting any trial, and confirm every detail on the trial's own ClinicalTrials.gov page.